BIOGEN LABS NPI 1821684515

NPI Details

BIOGEN LABS is a clinical medical laboratory in Stafford, TX. The provider is (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. BIOGEN LABS NPI is 1821684515. The provider is registered as an organization entity type.

The provider's business location address is:

4007 GREENBRIAR DR STE E
STAFFORD, TX
ZIP 77477-923
Phone: (478) 501-3866

The provider's authorized official is Asra Ahmed .
The authorized official title is Ceo and has the following contact phone number (478) 501-3866.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Gene analysis (coagulation factor ix) full sequence analysis (HCPCS:81238)
• Gene analysis (cystic fibrosis transmembrane conductance regular) full gene sequence (HCPCS:81223)
• Gene analysis (mpl proto-oncogene, thrombopoietin receptor) sequence analysis of exon 10 (HCPCS:81339)
• Molecular pathology procedure level 1 (HCPCS:81400)
• Gene analysis (partner and localizer of brca2) full sequence analysis (HCPCS:81307)
• Gene analysis (glucose-6-phosphate dehydrogenase) full sequence analysis (HCPCS:81249)
• Gene analysis (glucose-6-phosphatase, catalytic subunit) common variants (HCPCS:81250)
• Gene analysis (bloom syndrome, recq helicase-like) (HCPCS:81209)
• Gene analysis (fanconi anemia, complementation group c) common variant (HCPCS:81242)
• Gene analysis (muts homolog 6 [e coli]) full sequence analysis (HCPCS:81298)
• Gene analysis (postmeiotic segregation increased 2 [s cerevisiae]) full sequence analysis (HCPCS:81317)
• Gene analysis (janus kinase 2) targeted sequence analysis (HCPCS:81279)
• Gene analysis (frataxin) of full sequence (HCPCS:81286)
• Gene analysis (noonan syndrome) genomic sequence analysis (HCPCS:81442)
• Test for detecting genes associated with inherited disease of heart muscle (HCPCS:81439)
• Test for detecting genes associated with heart disease, genomic sequence analysis panel, at least 9 genes (HCPCS:81410)
• Test for detecting genes associated with heart disease, duplication/deletion analysis panel (HCPCS:81411)
• Molecular pathology procedure level 5 (HCPCS:81404)
• Molecular pathology procedure level 6 genetic analysis (HCPCS:81405)
• Molecular pathology procedure level 2 (HCPCS:81401)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Molecular pathology procedure level 4 (HCPCS:81403)

The enumeration date for this NPI number is 12/16/2020 and was last updated on 2/12/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: